Premium
Bosentan enhances in vitro bortezomib's anti‐proliferative potency against multiple myeloma by mechanisms going beyond endothelin receptor blockade
Author(s) -
Schäfer Julia,
Weiss Johanna,
Theile Dirk
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15241
Subject(s) - bosentan , bortezomib , blockade , potency , multiple myeloma , medicine , pharmacology , endothelin receptor , in vitro , cancer research , receptor , biology , biochemistry